Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP2A6 | P11509 | 5/20 | 0.39 |
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.39 |
| ▸ | CYP1A2 | P05177 | 5/20 | 0.39 |
| ▸ | TSHR | P16473 | 5/20 | 0.36 |
| ▸ | HSD17B10 | Q99714 | 4/20 | 0.36 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.36 |
| ▸ | HPGD | P15428 | 3/20 | 0.34 |
| ▸ | CYP3A4 | P08684 | 3/20 | 0.34 |
| ▸ | KEAP1 | Q14145 | 1/20 | 0.34 |
| ▸ | NR4A1 | P22736 | 1/20 | 0.34 |
| ▸ | NR4A2 | P43354 | 1/20 | 0.34 |
| ▸ | NR4A3 | Q92570 | 1/20 | 0.34 |
| ▸ | TP53 | P04637 | 2/20 | 0.34 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.34 |
| ▸ | ATM | Q13315 | 2/20 | 0.34 |
| ▸ | MAPT | P10636 | 2/20 | 0.34 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.34 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.34 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.34 |
| ▸ | NFKB2 | Q00653 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17966499 | 0.88 | CYP2A6 (0.44) | CYP2A6ALDH1A1CYP1A2TSHRHSD17B10 | |
| SCHEMBL12124319 | 0.80 | ESR1 (0.42) | CYP2A6ALDH1A1CYP1A2TSHRHSD17B10 | |
| SCHEMBL13964953 | 0.80 | ALDH1A1 (0.41) | CYP2A6ALDH1A1CYP1A2TSHRHSD17B10 | |
| SCHEMBL8207775 | 0.80 | CYP1A2 (0.41) | CYP2A6ALDH1A1CYP1A2TSHRHSD17B10 | |
| SCHEMBL31643929 | 0.80 | CYP1A2 (0.41) | CYP2A6ALDH1A1CYP1A2TSHRHSD17B10 | |
| SCHEMBL8216176 | 0.79 | CYP2A6 (0.44) | CYP2A6ALDH1A1CYP1A2TSHRHSD17B10 | |
| SCHEMBL10319492 | 0.79 | CYP2A6 (0.44) | CYP2A6ALDH1A1CYP1A2TSHRHSD17B10 | |
| SCHEMBL5063120 | 0.78 | CYP1A2 (0.45) | CYP2A6ALDH1A1CYP1A2TSHRHSD17B10 | |
| SCHEMBL11524427 | 0.77 | ALDH1A1 (0.39) | CYP2A6ALDH1A1CYP1A2TSHRHSD17B10 | |
| Potassium Ion SCHEMBL10641926 | 0.76 | ALDH1A1 (0.38) | CYP2A6ALDH1A1CYP1A2TSHRHSD17B10 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 18 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-5354772-A | Anticholesterol agents | SANDOZ PHARM. CORP. (US) | 1994-10-11 | — | — | US | disclosed |
| US-5001255-A | Idene analogs of mevalonolactone and derivatives thereof | SANDOZ PHARM. CORP. (US) | 1991-03-19 | — | — | US | disclosed |
| US-4973704-A | ANTICHOLESTEROL AGENTS | SANDOZ PHARM. CORP. (US) | 1990-11-27 | — | — | US | disclosed |
| EP-0235164-B1 | IMIDAZOLE ANALOGS OF MEVALONOLACTONE AND DERIVATIVES THEREOF | SANDOZ AG (CH) | 1990-07-25 | — | — | EP | disclosed |
| US-4876280-A | ANTICHOLESTEROL AGENTS; ATHEROSCLEROSIS; ANTILIPEMICS | SANDOZ PHARM. CORP. (US) | 1989-10-24 | — | — | US | disclosed |
| EP-0327500-A2 | 5-Substituted 1H-pyrazolo[3,4-b]pyridine derivatives, their preparation and pharmaceutical compositions containing them | SANDOZ AG (CH) | 1989-08-09 | — | — | EP | disclosed |
| US-4851427-A | INHJIBITORS OF CHOLESTEROL BIOSYNTHESIS | SANDOZ PHARM. CORP. (US) | 1989-07-25 | — | — | US | disclosed |
| US-4822799-A | Pyrazolopyridine analogs of mevalonolactone and derivatives thereof useful for inhibiting cholesterol biosynthesis in mammals | SANDOZ PHARM. CORP. (US) | 1989-04-18 | — | — | US | disclosed |
| US-4808607-A | ATHEROSCLEROSIS, HYPERLIPOPROTEINEMIA | SANDOZ PHARM. CORP. (US) | 1989-02-28 | — | — | US | disclosed |
| US-4804679-A | INHIBIT CHOLESTEROL BIOSYNTHESIS | SANDOZ PHARM. CORP. (US) | 1989-02-14 | — | — | US | disclosed |
| US-4755606-A | Imidazolyl-3,5-di-(diphenyl-butylsilyloxy) carboxylic acid ester intermediates | SANDOZ PHARM. CORP. (US) | 1988-07-05 | — | — | US | disclosed |
| US-4739073-A | ANTICHOLESTEROL AGENTS | SANDOZ PHARMACEUTICALS CORP. (US) | 1988-04-19 | — | — | US | disclosed |
| EP-0114027-B1 | ANALOGS OF MEVALOLACTONE AND DERIVATIVES THEREOF, PROCESSES FOR THEIR PRODUCTION, PHARMACEUTICAL COMPOSITIONS CONTAINING THEM AND THEIR USE AS PHARMACEUTICALS | SANDOZ AG (CH) | 1988-01-07 | — | — | EP | disclosed |
| EP-0235164-A1 | IMIDAZOLE ANALOGS OF MEVALONOLACTONE AND DERIVATIVES THEREOF. | SANDOZ AG (CH) | 1987-09-09 | — | — | EP | disclosed |
| US-4686237-A | LOWERING BLOOD CHOLESTEROL LEVEL | SANDOZ PHARMACEUTICALS CORP. (US) | 1987-08-11 | — | — | US | disclosed |
| US-4668794-A | CHOLESTEROL BIOSYNTHESIS INHIBITORS | SANDOZ PHARM. CORP. (US) | 1987-05-26 | — | — | US | disclosed |
| WO-1986007054-A1 | IMIDAZOLE ANALOGS OF MEVALONOLACTONE AND DERIVATIVES THEREOF | SANDOZ AG (CH) | 1986-12-04 | — | — | WO | disclosed |
| US-4613610-A | TREATING ATHEROSCLEROSIS AND HYPERLIPEMIA | SANDOZ PHARMACEUTICALS CORP. (US) | 1986-09-23 | — | — | US | disclosed |